June 21, 2021
- Clinical Management and Treatment: Updated recommendations for therapeutic anticoagulation and venous thromboembolism prophylaxis
- Clinical Management and Treatment: Revised tocilizumab dosing
May 6, 2021
- Testing & Clinical Management and Treatment: Revised Clearance Criteria for Lab Confirmed COVID-19 Inpatients section
April 23, 2021
- Clinical Management and Treatment: Revised Pharmacologic Management by Disease Severity section
- Clinical Management and Treatment: Added recommendations for therapeutic anticoagulation and venous thromboembolism prophylaxis
- Clinical Management and Treatment: Added recommendations for inhaled budesonide
- Clinical Management and Treatment: Added recommendations for colchicine
April 12, 2021
- Clinical Management and Treatment: Revised corticosteroid section
- Clinical Management and Treatment: Revised tocilizumab and sarilumab section
- Clinical Management and Treatment: Revised antibiotics section
January 13, 2021
- Clinical Management and Treatment: Added Pharmacologic Management by Disease Severity to summarize treatment options
- Clinical Management and Treatment: Added information for tocilizumab
- Clinical Management and Treatment: General clean-up of section
December 3, 2020
- Updated microbiology section
- Clinical Management and Treatment: Updated antibiotics section
- Clinical Management and Treatment: Added Pregnancy and Breastfeeding section
- Clinical Management and Treatment: Added information for remdesivir
July 29, 2020
- Updated microbiology and AGP guidance
- Updated diagnosis section
- Updated testing guidance
- Added corticosteroids to treatments section
- Revised Oseltamivir section
- Added information on Remdesivir
April 6, 2020
- Infection Prevention and Control: Updated language around aerosol generating procedures
- Testing: Updated to most recent testing guidelines for sample types